These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11709418)

  • 1. Endothelin antagonist reduces hemodynamic responses to vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; Wilson TW; McNeill JR
    Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2511-7. PubMed ID: 11709418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of endothelin and vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; McNeill JR
    Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin contributes to the hemodynamic effects of vasopressin in spontaneous hypertension.
    Balakrishnan SM; Gopalakrishnan V; McNeill JR
    Eur J Pharmacol; 1997 Sep; 334(1):55-60. PubMed ID: 9346328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total peripheral conductance mediates antihypertensive effect of nonpeptide mixed endothelin receptor antagonist in deoxycorticosterone acetate-salt hypertensive rats.
    Yu M; Gopalakrishnan V; McNeill JR
    Am J Hypertens; 1999 Aug; 12(8 Pt 1):845-8. PubMed ID: 10480481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of a selective endothelin--a receptor antagonist in deoxycorticosterone acetate-salt hypertensive rats.
    Yu M; Gopalakrishnan V; McNeill JR
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S262-4. PubMed ID: 9595455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of an endothelin antagonist on hemodynamic responses to angiotensin II.
    Balakrishnan SM; Wang HD; Gopalakrishnan V; Wilson TW; McNeill JR
    Hypertension; 1996 Nov; 28(5):806-9. PubMed ID: 8901827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy.
    Li JS; Larivière R; Schiffrin EL
    Hypertension; 1994 Aug; 24(2):183-8. PubMed ID: 8039842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin-1 expression in blood vessels of DOCA-salt hypertensive rats treated with the combined ETA/ETB endothelin receptor antagonist bosentan.
    Larivière R; Sventek P; Thibault G; Schiffrin EL
    Can J Physiol Pharmacol; 1995 Mar; 73(3):390-8. PubMed ID: 7544236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats.
    Schiffrin EL; Sventek P; Li JS; Turgeon A; Reudelhuber T
    Br J Pharmacol; 1995 Aug; 115(8):1377-81. PubMed ID: 8564194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
    Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M
    J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of a specific nonpeptide antagonist of substance P (NK-1) receptor in DOCA-salt hypertension.
    Kohlmann O; Ginoza M; Cezaretti ML; Zanella MT; Ribeiro AB; Tavares A; Ramos OL; Leeman SE; Gavras I; Gavras H
    Hypertension; 1995 Dec; 26(6 Pt 2):1186-9. PubMed ID: 7498993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of endogenous endothelin in the enhanced coronary constriction in DOCA-salt hypertensive rats.
    Millette E; de Champlain J; Lamontagne D
    J Hypertens; 2003 Jan; 21(1):115-23. PubMed ID: 12544443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of angiotensin receptors in the anterior hypothalamic preoptic area lowers blood pressure in DOCA-salt hypertensive rats.
    Kubo T; Yamaguchi H; Tsujimura M; Hagiwara Y; Fukumori R
    Hypertens Res; 2000 Mar; 23(2):109-18. PubMed ID: 10770257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different activation of vascular mitogen-activated protein kinases in spontaneously and DOCA-salt hypertensive rats.
    Kubo T; Ibusuki T; Saito E; Kambe T; Hagiwara Y
    Eur J Pharmacol; 2000 Jul; 400(2-3):231-7. PubMed ID: 10988339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic and regional hemodynamic effect of acute magnesium administration in the normotensive and hypertensive state.
    DiPette DJ; Simpson K; Guntupalli J
    Magnesium; 1987; 6(3):136-49. PubMed ID: 3626625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal function contributes to antihypertensive effect of vasopressin in DOCA-salt but not spontaneous hypertension.
    Wang H; McNeill JR
    Am J Physiol; 1994 Nov; 267(5 Pt 2):H1842-50. PubMed ID: 7977814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal and vascular effects of chronic endothelin receptor antagonism in malignant hypertensive rats.
    Li JS; Schürch W; Schiffrin EL
    Am J Hypertens; 1996 Aug; 9(8):803-11. PubMed ID: 8862227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acute vasopressin infusion on blood pressure and plasma angiotensin II in normotensive and DOCA-salt hypertensive rats.
    Morton JJ; Garcia del Rio C; Hughes MJ
    Clin Sci (Lond); 1982 Feb; 62(2):143-9. PubMed ID: 7053914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic hemodynamics in non-anesthetized L-NAME- and DOCA-salt-treated mice.
    Obst M; Gross V; Luft FC
    J Hypertens; 2004 Oct; 22(10):1889-94. PubMed ID: 15361759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.